Fewer than one in 10 patients prescribed an estradiol patch in Connecticut can fill their prescriptions within 30 days, according to patient data released by Women’s Health Connecticut.
The shortfall leaves thousands driving long distances and calling pharmacy after pharmacy for treatments they rely on to manage menopausal symptoms. Women’s Health Connecticut tracked more than 20,000 patients of menopausal age with hormone therapy orders in 2026, marking a 60 percent increase in orders compared to 2025.
Going without care can feel like a major setback for patients who spent months or years dealing with brain fog, sleepless nights, and hot flashes before finally finding relief. Providers are now urging patients not to stop or change their therapy independently.
Providers help patients switch estrogen forms and refill early
When patients cannot fill their patch, providers can help them switch to another form of estrogen. Options include a gel, spray, vaginal ring, pill, or a different patch strength or brand that may be easier to locate.
Medical teams are also sharing practical tips, from starting refill searches early to calling pharmacies before transferring a prescription. Patients can read the full guidance via the Women’s Health Connecticut resource page.
If symptoms return because of a treatment gap, providers want to know. Patients can bring refill concerns to their next appointment or call their office to work out a care plan.
Pushing for state and federal action
Healthcare providers are tracking prescription fill rates so lawmakers and regulators can witness the real impact on residents. Findings have already been shared with the Lieutenant Governor’s office.
Advocates are calling on Connecticut to reconvene its Prescription Drug Shortage Task Force, which was created by law in 2025. They also want state law updated so the task force must meet and deliver recommendations by January 2028.
Federal pressure is mounting as well, with Women’s Health Connecticut joining U.S. Senator Richard Blumenthal to urge the FDA to include estrogen patches on the national drug shortage list, find alternative suppliers, and extend expiration dates when appropriate.
Paula Greenberg, President and CEO of Women’s Health Connecticut, said the organization has been monitoring how many of its patients can fill their hormone therapy prescriptions, so lawmakers and regulators can see the real impact on Connecticut women, during an appearance covered by NBC Connecticut.
As manufacturers face calls to increase production and share regular availability updates, residents can contact their elected officials. Citizens can find their Connecticut legislators or find their members of Congress to ask for FDA intervention and support for the state task force.
Keep reading
- Maryland Marked Thanksgiving Twice in 1696, Governor Ordered
- Maine Standard Offer Electricity Rates Set for 2027, Modest Bill Increases Take Effect in January
- Menstrual Health Study Author Argues for Earlier Detection (archyde.com)
- South Korean Welfare Committee Increases Budget to Provide Oral Health Screenings for Seniors on Medical Aid (world-today-news.com)